BiotechTube

Ceftolozane / Tazobactam Injection

ApprovedTerminated
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pneumonia

Conditions

Pneumonia, Hematologic Malignancy, Pseudomonas Aeruginosa Infection, Bacteremia, Hematopoietic Stem Cell Transplant (HSCT)

Trial Timeline

Jan 10, 2023 → Mar 16, 2025

NCT ID
NCT04673175

About Ceftolozane / Tazobactam Injection

Ceftolozane / Tazobactam Injection is a approved stage product being developed by Merck for Pneumonia. The current trial status is terminated. This product is registered under clinical trial identifier NCT04673175. Target conditions include Pneumonia, Hematologic Malignancy, Pseudomonas Aeruginosa Infection.

What happened to similar drugs?

19 of 20 similar drugs in Pneumonia were approved

Approved (19) Terminated (3) Active (1)
✅doripenemJohnson & JohnsonApproved
✅Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe®MerckApproved
✅Imipenem + ImipenemMerckApproved
✅ceftriaxoneRocheApproved
✅Zavicefta, Ceftazidime-AvibactamPfizerApproved
✅Vancomycin + LinezolidPfizerApproved
✅Azithromycin + Ampicillin/sulbactamPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04673175ApprovedTerminated

Competing Products

20 competing products in Pneumonia

See all competitors
ProductCompanyStageHype Score
CAL02 Low-dose + CAL02 High-dose + PlaceboCombioxinPhase 1
19
tacrolimusAstellas PharmaPre-clinical
26
Cefiderocol + Best Available TherapyShionogiPhase 3
40
Cefiderocol + Meropenem + LinezolidShionogiPhase 3
40
Cefiderocol + Standard of Care AntibioticShionogiPhase 1
21
ONO-5046Na + ONO-5046NaOno PharmaceuticalPhase 2
35
doripenemJohnson & JohnsonApproved
43
levofloxacin; imipenem/cilastitinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 2/3
38
LevofloxacinJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
32
Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + DoripenemJohnson & JohnsonPhase 2
35
HRS-8427 + MeropenemJiangsu Hengrui MedicinePhase 2
42
Ceftazidime-avibactamAbbViePhase 1
21
Ticagrelor + PlaceboAstraZenecaPhase 2
27
Tedizolid phosphate + LinezolidMerckPhase 3
40
Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
32